Immunovant

$9.0M revenue • 50 employees • United States

Last Updated Mar 6, 2025

Company Overview

Company Name

Immunovant

Address

United States

Approx. Annual Revenue

$9.0M

Employees

50

Established

2016

About Immunovant

Immunovant, Inc. is a biopharmaceutical company based in the United States. The company is focused on developing treatments for autoimmune diseases, with a patient-centered approach to address the complex and variable needs of individuals affected by these conditions. Immunovant's pipeline includes ongoing clinical trials, and the company is committed to advancing new therapies to improve the lives of people with autoimmune diseases.

Business Profile

Read from the Immunovant website on Oct 13, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current copyright 2026; Clear navigation and content
Footer copyright year
2026

Biotech & Life Sciences Companies near CA

Browse all Biotech & Life Sciences companies in California →

Frequently Asked Questions about Immunovant

Categories

Technologies Used

Key Decision Makers

Steve Tisi Senior Director, Clinical Operations
LinkedIn
Farah Ali Vice President Clinical Development
LinkedIn
Aileen Ilaria Vice President Clinical Operations
LinkedIn
Joanne Dourado Sr Director, Clinical Operations-Site Relationship Mgmt
LinkedIn
Georgene Nathan Clinical Trial Manager
LinkedIn
Sagar Bhatt Senior Clinical Trial Associate
LinkedIn
Achint Chani Senior Clinical Trial Manager
LinkedIn
Jayme Hentig Director, Clinical Research Scientist
LinkedIn
Donella Colville Senior Clinical Trial Manager
LinkedIn
Sarah Mayo Clinical Trial Manager
LinkedIn